Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

SAN DIEGO, March 1, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical stage biopharmaceutical company, today reported financial results for the three- and twelve- month periods ended December 31, 2018. Fourth quarter and recent...

from PR Newswire: https://ift.tt/2To0rIc